Baxter (BAX) reports Q4 EPS of $0.97, not providing guidance for full-year 2020

Baxter (NYSE: BAX) reported Q4 EPS of $0.97, versus $0.71 reported last year. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.86 billion.

2020 Financial Outlook

At this time, given the high-degree of uncertainty around any potential negative financial impacts from COVID-19, Baxter is not providing guidance for full-year 2020. The company expects to provide an update in its first quarter 2020 earnings announcement on April 30, 2020.

For first-quarter 2020: The company expects sales growth of 4% to 5% on a reported basis and 5% to 6% on both a constant currency and operational basis. The company expects adjusted net income, before special items, of $0.72 to $0.74 per diluted share.

First-quarter operational sales estimates for 2020 have been adjusted for the impact of foreign exchange and the acquisition of Seprafilm.

Please see the schedules accompanying this press release for reconciliations of non-GAAP measures to the most closely related U.S. GAAP measures.

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• BuzzFeed (BZFD) Misses Q1 EPS by 53c, Revenue Misses; Offers Weak Q2 Guidance
• Vivani Medical, Inc. (VANI) Tops Q1 EPS by 2c
• Hall of Fame Resort & Entertainment (HOFV) Misses Q1 EPS by 230c